These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 11397539

  • 1. Mu opioid receptor efficacy and potency of morphine-6-glucuronide in neonatal guinea pig brainstem membranes: comparison with transfected CHO cells.
    Gray RE, Munks MW, Haynes RR, Olsen GD.
    Brain Res Bull; 2001 Mar 15; 54(5):499-505. PubMed ID: 11397539
    [Abstract] [Full Text] [Related]

  • 2. Up-regulation of spinal mu-opioid receptor function to activate G-protein by chronic naloxone treatment.
    Narita M, Mizoguchi H, Nagase H, Suzuki T, Tseng LF.
    Brain Res; 2001 Sep 21; 913(2):170-3. PubMed ID: 11549382
    [Abstract] [Full Text] [Related]

  • 3. Chronic in utero morphine exposure alters mu-agonist-stimulated [35S]-GTPgammaS binding in neonatal and juvenile guinea pig brainstem regions associated with breathing control.
    Matsuda AY, Olsen GD.
    Neurotoxicol Teratol; 2001 Sep 21; 23(5):413-9. PubMed ID: 11711243
    [Abstract] [Full Text] [Related]

  • 4. Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in guinea pig brain.
    Sim LJ, Childers SR.
    J Comp Neurol; 1997 Oct 06; 386(4):562-72. PubMed ID: 9378852
    [Abstract] [Full Text] [Related]

  • 5. [(35)S]GTPγS binding and opioid tolerance and efficacy in mouse spinal cord.
    Madia PA, Navani DM, Yoburn BC.
    Pharmacol Biochem Behav; 2012 Mar 06; 101(1):155-65. PubMed ID: 22108651
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pseudoginsenoside-F11 attenuates morphine-induced signalling in Chinese hamster ovary-mu cells.
    Li Z, Xu NJ, Wu CF, Xiong Y, Fan HP, Zhang WB, Sun Y, Pei G.
    Neuroreport; 2001 May 25; 12(7):1453-6. PubMed ID: 11388428
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
    Liu JG, Prather PL.
    Mol Pharmacol; 2001 Jul 25; 60(1):53-62. PubMed ID: 11408600
    [Abstract] [Full Text] [Related]

  • 10. Effects of chronic opioid exposure on guinea pig mu opioid receptor in Chinese hamster ovary cells: comparison with human and rat receptor.
    Wallisch M, Nelson CS, Mulvaney JM, Hernandez HS, Smith SA, Olsen GD.
    Biochem Pharmacol; 2007 Jun 01; 73(11):1818-28. PubMed ID: 17343833
    [Abstract] [Full Text] [Related]

  • 11. Antagonistic property of buprenorphine for putative epsilon-opioid receptor-mediated G-protein activation by beta-endorphin in pons/medulla of the mu-opioid receptor knockout mouse.
    Mizoguchi H, Wu HE, Narita M, Hall FS, Sora I, Uhl GR, Nagase H, Tseng LF.
    Neuroscience; 2002 Jun 01; 115(3):715-21. PubMed ID: 12435410
    [Abstract] [Full Text] [Related]

  • 12. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.
    Alt A, McFadyen IJ, Fan CD, Woods JH, Traynor JR.
    J Pharmacol Exp Ther; 2001 Jul 01; 298(1):116-21. PubMed ID: 11408532
    [Abstract] [Full Text] [Related]

  • 13. SoRI 9409, a non-peptide opioid mu receptor agonist/delta receptor antagonist, fails to stimulate [35S]-GTP-gamma-S binding at cloned opioid receptors.
    Xu H, Lu YF, Rice KC, Ananthan S, Rothman RB.
    Brain Res Bull; 2001 Jul 01; 55(4):507-11. PubMed ID: 11543951
    [Abstract] [Full Text] [Related]

  • 14. Effects of sodium on agonist efficacy for G-protein activation in mu-opioid receptor-transfected CHO cells and rat thalamus.
    Selley DE, Cao CC, Liu Q, Childers SR.
    Br J Pharmacol; 2000 Jul 01; 130(5):987-96. PubMed ID: 10882382
    [Abstract] [Full Text] [Related]

  • 15. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E, Tourwé D, Kertész I, Tóth G, Borsodi A, Benyhe S.
    Brain Res Bull; 2007 Sep 14; 74(1-3):119-29. PubMed ID: 17683797
    [Abstract] [Full Text] [Related]

  • 16. Mu and kappa1 opioid-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in cynomolgus monkey brain.
    Sim-Selley LJ, Daunais JB, Porrino LJ, Childers SR.
    Neuroscience; 1999 Sep 14; 94(2):651-62. PubMed ID: 10579225
    [Abstract] [Full Text] [Related]

  • 17. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
    Yadlapalli JSK, Ford BM, Ketkar A, Wan A, Penthala NR, Eoff RL, Prather PL, Dobretsov M, Crooks PA.
    Pharmacol Res; 2016 Nov 14; 113(Pt A):335-347. PubMed ID: 27637375
    [Abstract] [Full Text] [Related]

  • 18. Morphine-6-O-beta-D-glucuronide but not morphine-3-O-beta-D-glucuronide binds to mu-, delta- and kappa- specific opioid binding sites in cerebral membranes.
    Löser SV, Meyer J, Freudenthaler S, Sattler M, Desel C, Meineke I, Gundert-Remy U.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul 14; 354(2):192-7. PubMed ID: 8857597
    [Abstract] [Full Text] [Related]

  • 19. G protein activation by endomorphins in the mouse periaqueductal gray matter.
    Narita M, Mizoguchi H, Narita M, Dun NJ, Hwang BH, Endoh T, Suzuki T, Nagase H, Suzuki T, Tseng LF.
    J Biomed Sci; 2000 Jul 14; 7(3):221-5. PubMed ID: 10810240
    [Abstract] [Full Text] [Related]

  • 20. Relationship between rate and extent of G protein activation: comparison between full and partial opioid agonists.
    Traynor JR, Clark MJ, Remmers AE.
    J Pharmacol Exp Ther; 2002 Jan 14; 300(1):157-61. PubMed ID: 11752111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.